Check out the latest news and insights from DrugDev

DrugDev would like to congratulate our partners Eisai and AstraZeneca for their recognition in MAGI’s first ever Awards for Excellence in Site Payments. MAGI awarded Eisai with “Winner, Most Consistent Over Time,” and AstraZeneca with “Runner-Up, Most Consistent Over Time.” DrugDev is proud to work with both Eisai and AstraZeneca to deliver quality payments on time for site investigators worldwide. MAGI created the Site Payments award this year to recognize sponsors and CROs for their efforts to pay sites quickly throughout 2016.

DrugDev also congratulates Sunovion for their award for “Winner, Fastest in 2016.” Site payments remain one of the biggest issues in clinical trials today and DrugDev believes these companies should be recognized for their work. 

Read more here.